InvestorsHub Logo
Followers 11
Posts 1326
Boards Moderated 0
Alias Born 07/07/2009

Re: None

Thursday, 11/17/2016 8:32:51 AM

Thursday, November 17, 2016 8:32:51 AM

Post# of 6443
Companies discussed in this Pre-Eclampsia Pipeline Review, H2 2016 report include A1M Pharma AB, Alnylam Pharmaceuticals, Inc., Glenveigh Medical, LLC, LFB S.A., Pluristem Therapeutics Inc. and VG Life Sciences, Inc. Drug Profiles mentioned in this research report are A1M-001, ALN-AGT, antithrombin (recombinant), digoxin immune fab, PLX-PAD, RMC-035, Small Molecules to Agonize Apelin Receptor for Pre-Eclampsia and VG-1177.